Keywords: cpmp, backing, means, lundbeck, moves, close, approval

CPMP backing means Lundbeck moves close to approval of Ebixa for Alzheimer's

Article | 25 February 2002

Print This

Denmark's Lundbeck is gearing up for a possible launch of its newAlzheimer's disease treatment Ebixa (memantine) in the second half ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in